NHS-IL12 and bintrafusp alfa combination therapy enhances antitumor activity in preclinical cancer models

Combinatorial immunotherapy approaches are emerging as viable cancer therapeutic strategies for improving patient responses and outcomes. This study investigated whether two such immunotherapies, with complementary mechanisms of action, could enhance antitumor activity in murine tumor models. The im...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Chunxiao, Marelli, Bo, Qi, Jin, Qin, Guozhong, Yu, Huakui, Wang, Hong, Jenkins, Molly H., Lo, Kin-Ming, Lan, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718653/
https://www.ncbi.nlm.nih.gov/pubmed/34954456
http://dx.doi.org/10.1016/j.tranon.2021.101322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718653/
https://www.ncbi.nlm.nih.gov/pubmed/34954456
http://dx.doi.org/10.1016/j.tranon.2021.101322

Ejemplares similares